Excretion of Rivaroxaban in Human Breast Milk (NCT06831474)

🧪 Interventions in This Study

• Rivaroxaban 10 MG Oral Tablet (DRUG)
• Rivaroxaban 20 MG Oral Tablet (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania

📞 Contact the Study Coordinator

Phone: (215) 955-5500

Email: sophie.green@jefferson.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Postpartum

• Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs — Chicago, Illinois
• Digital Maternal Support Tool Implementation — Pittsburgh, Pennsylvania
• Orthopaedic Manual Physical Therapy as Part of the Postpartum Care Continuum — San Antonio, Texas
• HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring — Minneapolis, Minnesota
• Drug Excretion in Breast Milk — Seattle, Washington

Explore by condition: All Postpartum clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.